NextCure NXTC
NASDAQ NXTC
$6.40 +0.17 (+2.73%)
At close: Nov 13, 2026 · 4:00 PM EST

NextCure (NXTC) Net Margin (2019 - 2020)

Updated

NextCure (NXTC) recorded Net Margin of -163.57% in FY2020, up 367.98 percentage points from -531.54% in FY2019.

Analysis

NextCure (NXTC) Net Margin (2019 - 2020) Analysis & Trends

  • Per Business Quant data, NXTC's Net Margin was -531.54% in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 26.44%
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 0.83%
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 24.24%
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 28.01%
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 20.69%
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 37.28%
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 29.27%
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 19.55%
10 NextCure 29.30 Mn -71.08 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 43.49%
Dec 31, 2019 -544.99%
Sep 30, 2019 -532.79%
Jun 30, 2019 -586.38%
Mar 31, 2019 -453.57%
API Access

NextCure Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=NXTC&period=max&api_key=YOUR_API_KEY